Enhance.MD vs. Oak Longevity: prices, fine print, and the honest verdict

Tirzepatide pricing

Enhance.MD does not offer tirzepatide. Oak Longevity does not offer tirzepatide.

Semaglutide pricing

On semaglutide, Oak Longevity wins at $133 versus $249 all-in — $116/mo apart. Enhance.MD: Semaglutide runs $249 a month all-in at the standing rate ($212 on intro/plan terms). Oak Longevity: Semaglutide runs $133 a month all-in.

Transparency

Enhance.MD: Source-verified (verified 2026-08-08); dispensing pharmacy not publicly named. Oak Longevity: Source-verified (verified 2026-08-08); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Enhance.MD: none month-to-month; term plans paid per schedule. Oak Longevity: none stated; no subscription.

The semaglutide board

On semaglutide, Oak Longevity prices at $133 against $249 all-in. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. Enhance.MD publishes no figure to normalize; Oak Longevity publishes no figure to normalize. 4 · Evidence tiered. Enhance.MD: source-verified, read 2026-08-08; Oak Longevity: source-verified, read 2026-08-08. 5 · Pharmacy weighed. Enhance.MD names no pharmacy; Oak Longevity names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Enhance.MD: no membership — the medication figure is the billed figure; prepaid 12-month plan at $212/mo effective; term plans paid per schedule; commitment: none month-to-month. Oak Longevity: no membership — the medication figure is the billed figure; no subscription; commitment: none stated. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Enhance.MD carries source-verified pricing (last read 2026-08-08); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Oak Longevity carries source-verified pricing (last read 2026-08-08); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from Enhance.MD to Oak Longevity (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: Enhance.MD: shipping included; consultation included; async visit model. Oak Longevity: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Enhance.MD if you'll prepay for the $212 effective rate. Pick Oak Longevity if the semaglutide line is cheaper here. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.